TY - JOUR
T1 - Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023
AU - et l'ensemble des experts des votes des RPC Saint-Paul 2022-2023
AU - Gligorov, Joseph
AU - Benderra, Marc Antoine
AU - Barthere, Xavier
AU - de Forceville, Louise
AU - Antoine, Eric Charles
AU - Cottu, Paul Henri
AU - Delaloge, Suzette
AU - Pierga, Jean Yves
AU - Belkacemi, Yazid
AU - Houvenaegel, Gilles
AU - Pujol, Pascal
AU - Rivera, Sofia
AU - Spielmann, Marc
AU - Penault-Llorca, Frédérique
AU - Namer, Moise
AU - Aapro, Matti
AU - Al-Ghazali, Hesham
AU - Bachelot, Thomas
AU - Barranger, Emmanuel
AU - Berrada, Narjiss
AU - Bidard, François Clément
AU - Bounedjar, Adda
AU - Boussen, Hamouda
AU - Campone, Mario
AU - Cardoso, Fatima
AU - Ceugnart, Luc
AU - Classe, Jean Marc
AU - Cohen, Monique
AU - Coutant, Charles
AU - Cutuli, Bruno
AU - Dalenc, Florence
AU - Dieras, Véronique
AU - Dohollou, Nadine
AU - Giacchetti, Sylvie
AU - Goncalves, Anthony
AU - Freyer, Gilles
AU - Hannoun-Levi, Jean Michel
AU - Hardy-Bessard, Anne Claire
AU - Jacquin, Jean Philippe
AU - Jacot, William
AU - Kerrou, Khaldoun
AU - Ladoire, Sylvain
AU - Lerebours, Florence
AU - Levy, Christelle
AU - Llombart-Cussac, Antonio
AU - Loirat, Delphine
AU - Thomassin, Isabelle
AU - Piccart, Martine
AU - Petit, Thierry
AU - Radosevic-Robin, Nina
N1 - Publisher Copyright:
© 2023 Elsevier Masson SAS. Tous droits réservés.
PY - 2023/11/1
Y1 - 2023/11/1
N2 - With more than 60,000 new cases of breast cancer in mainland France in 2023 and 8% of all cancer deaths, breast cancer is the leading cancer in women in terms of incidence and mortality. While the number of new cases has almost doubled in 30 years, the percentage of patients at all stages alive at 5 years (87%) and 10 years (76%) testifies to the major progress made in terms of screening, characterisation and treatment. However, this progress, rapid as it is, needs to be evaluated and integrated into an overall strategy, taking into account the characteristics of the disease (stage and biology), as well as those of the patients being treated. These are the objectives of the St Paul-de-Vence recommendations for clinical practice. We report here the summary of the votes, discussions and conclusions of the Saint-Paul-de-Vence 2022-2023 RPCs.
AB - With more than 60,000 new cases of breast cancer in mainland France in 2023 and 8% of all cancer deaths, breast cancer is the leading cancer in women in terms of incidence and mortality. While the number of new cases has almost doubled in 30 years, the percentage of patients at all stages alive at 5 years (87%) and 10 years (76%) testifies to the major progress made in terms of screening, characterisation and treatment. However, this progress, rapid as it is, needs to be evaluated and integrated into an overall strategy, taking into account the characteristics of the disease (stage and biology), as well as those of the patients being treated. These are the objectives of the St Paul-de-Vence recommendations for clinical practice. We report here the summary of the votes, discussions and conclusions of the Saint-Paul-de-Vence 2022-2023 RPCs.
KW - Breast cancer
KW - Early breast cancer
KW - Guidelines
KW - Metastatic breast cancer
KW - Saint-Paul
UR - http://www.scopus.com/inward/record.url?scp=85179106644&partnerID=8YFLogxK
U2 - 10.1016/S0007-4551(23)00473-3
DO - 10.1016/S0007-4551(23)00473-3
M3 - Article
AN - SCOPUS:85179106644
SN - 0007-4551
VL - 110
SP - 10S1-10S43
JO - Bulletin du Cancer
JF - Bulletin du Cancer
IS - 10
ER -